litlas
ログインアカウント作成

Charles A. Gersbach

2004–2025 年に発表

87
論文数
21,962
被引用数
65
h 指数
81
i10 指数

被引用数

Charles A. Gersbach の年別被引用数1983 年: 被引用 4 件1993 年: 被引用 1 件1999 年: 被引用 3 件2003 年: 被引用 1 件2004 年: 被引用 1 件2005 年: 被引用 6 件2006 年: 被引用 15 件2007 年: 被引用 4 件2008 年: 被引用 10 件2009 年: 被引用 11 件2010 年: 被引用 15 件2011 年: 被引用 7 件2012 年: 被引用 18 件2013 年: 被引用 107 件2014 年: 被引用 223 件2015 年: 被引用 307 件2016 年: 被引用 435 件2017 年: 被引用 421 件2018 年: 被引用 408 件2019 年: 被引用 1,067 件2020 年: 被引用 1,184 件2021 年: 被引用 1,154 件2022 年: 被引用 1,005 件2023 年: 被引用 762 件2024 年: 被引用 1,093 件2025 年: 被引用 596 件2026 年: 被引用 11 件1984〜1992 年は被引用が無いため表示していません1994〜1998 年は被引用が無いため表示していません2000〜2002 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,850 件、この内訳の 31%中国: 引用元論文 1,428 件、この内訳の 15.5%イギリス: 引用元論文 490 件、この内訳の 5.3%ドイツ: 引用元論文 480 件、この内訳の 5.2%インド: 引用元論文 320 件、この内訳の 3.5%日本: 引用元論文 255 件、この内訳の 2.8%カナダ: 引用元論文 225 件、この内訳の 2.5%フランス: 引用元論文 213 件、この内訳の 2.3%オーストラリア: 引用元論文 212 件、この内訳の 2.3%韓国: 引用元論文 212 件、この内訳の 2.3%イタリア: 引用元論文 206 件、この内訳の 2.2%オランダ: 引用元論文 198 件、この内訳の 2.2%
0%31%その他 22.9%

機関

分野

  • Biochemistry, Genetics and Molecular Biology79.1%
  • Medicine11.1%
  • Neuroscience2.5%
  • Agricultural and Biological Sciences2.4%
  • Engineering1.5%
  • Immunology and Microbiology1.4%
  • その他2%

トピック

  • CRISPR and Genetic Engineering19.3%
  • RNA Interference and Gene Delivery4.1%
  • Advanced biosensing and bioanalysis techniques3.8%
  • Virus-based gene therapy research3.8%
  • RNA and protein synthesis mechanisms3.7%
  • Pluripotent Stem Cells Research2.9%
  • その他62.4%

共著者

全論文

検索で開く
  1. The next generation of CRISPR–Cas technologies and applications

    著者: Adrian Pickar‐Oliver, Charles A. Gersbach - Nature Reviews Molecular Cell Biology 2019 被引用: 1,493

  2. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering

    著者: Thomas Gaj, Charles A. Gersbach, Carlos F. Barbas - Trends in biotechnology 2013 被引用: 3,774

  3. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers

    著者: Isaac B. Hilton, Anthony D’Ippolito, Christopher M. Vockley, Pratiksha I. Thakore, Gregory E. Crawford, Timothy E. Reddy, Charles A. Gersbach - Nature Biotechnology 2015 被引用: 1,876

  4. RNA-guided gene activation by CRISPR-Cas9–based transcription factors

    著者: Pablo Pérez‐Piñera, D. Dewran Koçak, Christopher M. Vockley, Andrew F. Adler, Ami M. Kabadi, Lauren R. Polstein, Pratiksha I. Thakore, Katherine A. Glass, David G. Ousterout, Kam W. Leong, Farshid Guilak, Gregory E. Crawford, Timothy E. Reddy, Charles A. Gersbach - Nature Methods 2013 被引用: 1,349

  5. Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements

    著者: Pratiksha I. Thakore, Anthony D’Ippolito, Lingyun Song, Alexias Safi, Nishkala K. Shivakumar, Ami M. Kabadi, Timothy E. Reddy, Gregory E. Crawford, Charles A. Gersbach - Nature Methods 2015 被引用: 1,045

  6. The once and future gene therapy

    著者: Karen Bulaklak, Charles A. Gersbach - Nature Communications 2020 被引用: 322

  7. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy

    著者: Christopher E. Nelson, Chady H. Hakim, David G. Ousterout, Pratiksha I. Thakore, Eirik A. Moreb, Ruth M. Castellanos Rivera, Sarina Madhavan, Xiufang Pan, F. Ann Ran, Winston X. Yan, Aravind Asokan, Feng Zhang, Dongsheng Duan, Charles A. Gersbach - Science 2015 被引用: 1,152

  8. Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy

    著者: Christopher E. Nelson, Yaoying Wu, Matthew Gemberling, Matthew L. Oliver, Matthew A. Waller, Joel D. Bohning, Jacqueline N. Robinson-Hamm, Karen Bulaklak, Ruth M. Castellanos Rivera, Joel H. Collier, Aravind Asokan, Charles A. Gersbach - Nature Medicine 2019 被引用: 429

  9. Increasing the specificity of CRISPR systems with engineered RNA secondary structures

    著者: D. Dewran Koçak, Eric A. Josephs, Vidit Bhandarkar, Shaunak Adkar, Jennifer B. Kwon, Charles A. Gersbach - Nature Biotechnology 2019 被引用: 361

  10. Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models

    著者: Chady H. Hakim, Sandeep Kumar, Dennis O. Pérez‐López, Nalinda B. Wasala, Dong Zhang, Yongping Yue, James Teixeira, Xiufang Pan, Keqing Zhang, Emily D. Million, Christopher E. Nelson, Samantha Metzger, Jin-Young Han, Jacqueline A. Louderman, Florian Schmidt, Feng Feng, Dirk Grimm, B. F. Smith, Gang Yao, N. Nora Yang, Charles A. Gersbach, Shi‐Jie Chen, Roland W. Herzog, Dongsheng Duan - Nature Communications 2021 被引用: 170

  11. Editing the epigenome: technologies for programmable transcription and epigenetic modulation

    著者: Pratiksha I. Thakore, Joshua B. Black, Isaac B. Hilton, Charles A. Gersbach - Nature Methods 2016 被引用: 448

  12. Genome-editing Technologies for Gene and Cell Therapy

    著者: Morgan L. Maeder, Charles A. Gersbach - Molecular Therapy 2016 被引用: 718

  13. A light-inducible CRISPR-Cas9 system for control of endogenous gene activation

    著者: Lauren R. Polstein, Charles A. Gersbach - Nature Chemical Biology 2015 被引用: 651

  14. CRISPR–Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome

    著者: Tyler S. Klann, Joshua B. Black, Malathi Chellappan, Alexias Safi, Lingyun Song, Isaac B. Hilton, Gregory E. Crawford, Timothy E. Reddy, Charles A. Gersbach - Nature Biotechnology 2017 被引用: 470

  15. Transcriptional and epigenetic regulators of human CD8+ T cell function identified through orthogonal CRISPR screens

    著者: Sean R. McCutcheon, Adam M. Swartz, Michael C. Brown, Alejandro Barrera, Christian McRoberts Amador, Keith Siklenka, Lucas Humayun, Maria A. ter Weele, James Isaacs, Timothy E. Reddy, Andrew S. Allen, Smita K. Nair, Scott J. Antonia, Charles A. Gersbach - Nature Genetics 2023 被引用: 78

  16. Transgenic mice for in vivo epigenome editing with CRISPR-based systems

    著者: Matthew Gemberling, Keith Siklenka, Erica Rodriguez, Katherine R. Tonn Eisinger, Alejandro Barrera, Fang Liu, Ariel Kantor, Liqing Li, Valentina Cigliola, Mariah F. Hazlett, Courtney Williams, Luke C. Bartelt, Victoria J. Madigan, Josephine C. Bodle, Heather Daniels, Douglas Rouse, Isaac B. Hilton, Aravind Asokan, Maria Ciofani, Kenneth D. Poss, Timothy E. Reddy, Anne E. West, Charles A. Gersbach - Nature Methods 2021 被引用: 138

  17. Epigenome editing technologies for discovery and medicine

    著者: Sean R. McCutcheon, Dahlia Rohm, Nahid Iglesias, Charles A. Gersbach - Nature Biotechnology 2024 被引用: 95

  18. Cross-species evolution of a highly potent AAV variant for therapeutic gene transfer and genome editing

    著者: Trevor Gonzalez, Katherine E. Simon, Leo O. Blondel, Marco M. Fanous, Angela L. Roger, Maribel Santiago Maysonet, Garth Devlin, Timothy J. Smith, Daniel K. Oh, L. Patrick Havlik, Ruth M. Castellanos Rivera, Jorge A. Piedrahita, Mai K. ElMallah, Charles A. Gersbach, Aravind Asokan - Nature Communications 2022 被引用: 81

  19. Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector

    著者: Ami M. Kabadi, David G. Ousterout, Isaac B. Hilton, Charles A. Gersbach - Nucleic Acids Research 2014 被引用: 388

  20. RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors

    著者: Pratiksha I. Thakore, Jennifer B. Kwon, Christopher E. Nelson, Douglas Rouse, Matthew Gemberling, Matthew L. Oliver, Charles A. Gersbach - Nature Communications 2018 被引用: 174

  21. Enhancer Histone Acetylation Modulates Transcriptional Bursting Dynamics of Neuronal Activity-Inducible Genes

    著者: Liang-Fu Chen, Yen Ting Lin, David A. Gallegos, Mariah F. Hazlett, Mariana Gómez-Schiavon, Marty G. Yang, Breanna Kalmeta, Allen S. Zhou, Liad Holtzman, Charles A. Gersbach, Jörg Grandl, Nicolas E. Buchler, Anne E. West - Cell Reports 2019 被引用: 177

  22. Multicenter integrated analysis of noncoding CRISPRi screens

    著者: David Yao, Josh Tycko, Jin Woo Oh, Lexi R. Bounds, Sager J. Gosai, Lazaros Lataniotis, Ava Mackay-Smith, Benjamin R. Doughty, Idan Gabdank, Henri Schmidt, Tania Guerrero-Altamirano, Keith Siklenka, Katherine Guo, Alexander D. White, Ingrid Youngworth, Kalina Andreeva, Xingjie Ren, Alejandro Barrera, Yunhai Luo, Galip Gürkan Yardımcı, Ryan Tewhey, Anshul Kundaje, William J. Greenleaf, Pardis C. Sabeti, Christina S. Leslie, Yuri Pritykin, Jill E. Moore, M Beer, Charles A. Gersbach, Timothy E. Reddy, Yin Shen, J Engreitz, Michael C. Bassik, Steven K. Reilly - Nature Methods 2024 被引用: 50

  23. Full-length dystrophin restoration via targeted exon integration by AAV-CRISPR in a humanized mouse model of Duchenne muscular dystrophy

    著者: Adrian Pickar‐Oliver, Veronica Gough, Joel D. Bohning, Siyan Liu, Jacqueline N. Robinson-Hamm, Heather Daniels, William H. Majoros, Garth Devlin, Aravind Asokan, Charles A. Gersbach - Molecular Therapy 2021 被引用: 67

  24. Branched-chain α-ketoacids are preferentially reaminated and activate protein synthesis in the heart

    著者: Jacquelyn M. Walejko, Bridgette A. Christopher, Scott B. Crown, Guofang Zhang, Adrian Pickar‐Oliver, Takeshi Yoneshiro, Matthew W. Foster, Stephani C. Page, Stephan van Vliet, Olga Ilkayeva, Michael J. Muehlbauer, Matthew W. Carson, Joseph T. Brozinick, Craig D. Hammond, Ruth E. Gimeno, M. Arthur Moseley, Shingo Kajimura, Charles A. Gersbach, Christopher B. Newgard, Phillip J. White, Robert W. McGarrah - Nature Communications 2021 被引用: 97